Author/Authors :
Andisheh Tadbir، Azadeh نويسنده Department of Oral Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran , , Ashraf، Mohammad Javad نويسنده , , Moradi، Mina نويسنده Student Research Committee,School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran ,
Abstract :
Background: Angiogenesis is essential for the growth, invasion and metastasis of
solid tumors. Research on related factors such as microvessel density can be helpful
in predicting a tumorʹs behavior. CD105 has been introduced as a marker of angiogenesis
which stains vessels that are in the proliferating stage. There are some controversies
about the relation of microvessel density and clinicopathological features of oral
squamous cell carcinoma. The aim of this study is to determine the CD105 expression
in oral squamous cell carcinoma and its relation to the clinicopathological features of
this disease.
Methods: We studied a total of 42 patients who had oral squamous cell carcinoma.
The control group consisted of 15 cases with normal oral epithelium. CD105
immunostaining was performed on 4 ?m thick tissue sections. Intratumoral and
peritumoral microvessel density in ten areas of the sections were recorded by two
pathologists.
Results: There was a significantly higher CD105 microvessel density value in the
tumoral tissues compared with normal tissues. In addition, there was more expression
of this marker in the invasive front area. The CD105 microvessel density value had a
positive relation with lymph node metastasis. There was an association between tumor
size and CD105 microvessel density in the invasive front region. A negative association
between tumor grade and CD105 microvessel density value in the intratumoral region
was observed. In both areas, CD105 expression was higher in cases with advanced
clinical stage. There was no association between this marker and patientsʹ ages or gender.
Conclusion: CD105 microvessel density can be a useful factor for predicting the
course of oral squamous cell carcinoma.